Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Diversity, Equity, Inclusion, and Accessibility, 8023-8024 [2022-02972]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 29 / Friday, February 11, 2022 / Notices
Date: March 15–16, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bo Hong, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict—Lung Disorders.
Date: March 15–16, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: George M. Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4220,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Anti-Infective Therapeutics.
Date: March 15–16, 2022.
Time: 9:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20894, 301–435–4057, bidyottam.mittra@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Health
Promotion in Communities: Vaccine
Hesitancy.
Date: March 15, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Tisdale Wigfall, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007G,
Bethesda, MD 20892, (301) 594–5622,
wigfalllt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; The BloodBrain Barrier, Neurovascular Systems and
CNS Therapeutics.
Date: March 16, 2022.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Linda MacArthur, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
VerDate Sep<11>2014
17:29 Feb 10, 2022
Jkt 256001
Health, 6701 Rockledge Drive, Room 4187,
Bethesda, MD 20892, 301–537–9986,
macarthurlh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Musculoskeletal, Rehabilitation
and Skin Sciences.
Date: March 16–17, 2022.
Time: 10:00 a.m. to 10:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Carmen Bertoni, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 805B,
Bethesda, MD 20892, (301) 867–5309,
bertonic2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular and Surgical
Devices.
Date: March 17–18, 2022.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Willard Wilson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Bethesda, MD
20817, 301–867–5309, willard.wilson@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
21–026: Tissue Mapping Centers for the
Human BioMolecular Atlas Program (U54).
Date: March 17–18, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Raj K. Krishnaraju, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6190,
Bethesda, MD 20892, 301–435–1047,
kkrishna@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Infectious, Foodborne and
Waterborne Disease Diagnostics and Methods
in Microbial Sterilization and Disinfection.
Date: March 17–18, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 3200,
MSC 7808, Bethesda, MD 20892, (301) 435–
1167, pandyaga@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
117: Maximizing Investigators’ Research
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
8023
Award (MIRA) for Early Stage Investigators
(R35—Clinical Trial Optional).
Date: March 17–18, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kevin Czaplinski, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6901 Rockledge Drive,
Bethesda, MD 20892, (301) 480–9139,
czaplinskik2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 7, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02903 Filed 2–10–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information (RFI): Inviting
Comments and Suggestions on a
Framework for the NIH-Wide Strategic
Plan for Diversity, Equity, Inclusion,
and Accessibility
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This Request for Information
(RFI) is intended to gather broad public
input to assist the National Institutes of
Health (NIH) in developing the NIHWide Strategic Plan for Diversity,
Equity, Inclusion, and Accessibility
(DEIA). NIH invites input from
stakeholders throughout the scientific
research, advocacy, and clinical practice
communities, as well as the general
public, regarding the proposed
framework for the NIH-Wide Strategic
Plan for DEIA. Organizations are
strongly encouraged to submit a single
response that reflects the views of their
organization and their membership as a
whole.
DATES: This RFI is open for public
comment for a period of 60 days.
Comments must be received by 11:59:59
p.m. (ET) on April 3, 2022, to ensure
consideration.
SUMMARY:
All comments must be
submitted electronically on the
submission website available at https://
rfi.grants.nih.gov/?s=
61e9a09a971100006d005012.
ADDRESSES:
E:\FR\FM\11FEN1.SGM
11FEN1
8024
Federal Register / Vol. 87, No. 29 / Friday, February 11, 2022 / Notices
NIH-Wide Strategic Plan for DEIA
Framework
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to: Marina
Volkov, nihstrategicplan@od.nih.gov,
301–496–4147.
The
purpose of the NIH-Wide Strategic Plan
for DEIA is to articulate NIH’s vision for
embracing, integrating, and
strengthening DEIA across all NIH
activities to achieve the NIH mission.
The Strategic Plan will capture activities
that NIH will undertake to meet the
vision of the Strategic Plan, and will be
organized around accomplishments,
needs, opportunities, and challenges in
addressing DEIA in the NIH internal and
extramural workforce, its structure and
culture, and the research it supports.
NIH has implemented a range of other
initiatives to advance DEIA. Among
them, the UNITE initiative (https://
www.nih.gov/ending-structural-racism/
unite) was established in 2021 to
identify and address structural racism
within the NIH-supported and the
greater scientific community. Please
note that an RFI on the Draft 2022–2026
Chief Officer for Scientific Workforce
Diversity (COSWD) Strategic Plan
(https://grants.nih.gov/grants/guide/
notice-files/NOT-OD-22-054.html) was
released on January 12, 2022 and,
therefore, is open for public comment at
the same time as this Framework for the
NIH-Wide Strategic Plan for DEIA. You
are encouraged to respond to both.
The NIH-Wide Strategic Plan for DEIA
is being developed in part as a response
to Report 116–450 on H.R. 7614:
Diversity at NIH Working Group and
Strategic Plan, and is responsive to
Executive Order 14035 and the
Government-Wide Strategic Plan to
Advance Diversity, Equity, Inclusion,
and Accessibility in the Federal
Workforce (https://
www.whitehouse.gov/briefing-room/
presidential-actions/2021/06/25/
executive-order-on-diversity-equityinclusion-and-accessibility-in-thefederal-workforce/).
The NIH-Wide Strategic Plan for DEIA
will highlight NIH’s ongoing and future
efforts to foster DEIA within the
biomedical and health research
enterprise. The Framework for the NIHWide Strategic Plan for DEIA, below,
articulates NIH’s priorities in three key
areas (Objectives): Organizational
practices to center and prioritize DEIA
within the workforce; broad efforts to
manage and sustain DEIA through
structural and cultural change; and
research to promote both workforce and
health equity. These Objectives apply
across NIH.
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:29 Feb 10, 2022
Jkt 256001
Objective 1: Implement Organizational
Practices To Center and Prioritize DEIA
in the Workforce
• NIH Workforce
• Workforce at Institutions Supported
by NIH Funding
Objective 2: Grow and Sustain DEIA
Through Structural and Cultural
Change
•
•
•
•
Stewardship
Partnerships and Engagements
Accountability and Confidence
Management and Operations
Objective 3: Advance DEIA Through
Research
• Workforce Research
• Health Research
The NIH seeks comments on any or
all of NIH’s priorities across the three
key areas (Objectives) articulated in the
framework, including potential benefits,
drawbacks or challenges, and other
priority areas for consideration.
NIH encourages organizations (e.g.,
patient advocacy groups, professional
organizations) to submit a single
response reflective of the views of the
organization or membership as a whole.
Responses to this RFI are voluntary
and may be submitted anonymously.
Please do not include any personally
identifiable information or any
information that you do not wish to
make public. Proprietary, classified,
confidential, or sensitive information
should not be included in your
response. The Government will use the
information submitted in response to
this RFI at its discretion. The
Government reserves the right to use
any submitted information on public
websites, in reports, in summaries of the
state of the science, in any possible
resultant solicitation(s), grant(s), or
cooperative agreement(s), or in the
development of future funding
opportunity announcements. This RFI is
for informational and for planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the Government to provide
support for any ideas identified in
response to it. Please note that the
Government will not pay for the
preparation of any information
submitted or for use of that information.
We look forward to your input and
hope that you will share this RFI
opportunity with your colleagues.
PO 00000
Frm 00033
Fmt 4703
Sfmt 9990
Dated: February 7, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2022–02972 Filed 2–10–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel;
Immunometabolism and Aging.
Date: February 23, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Kimberly Firth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, Gateway Building, 7201
Wisconsin Avenue, Suite 2W200, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 7, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–02918 Filed 2–10–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 87, Number 29 (Friday, February 11, 2022)]
[Notices]
[Pages 8023-8024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02972]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information (RFI): Inviting Comments and Suggestions
on a Framework for the NIH-Wide Strategic Plan for Diversity, Equity,
Inclusion, and Accessibility
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Request for Information (RFI) is intended to gather broad
public input to assist the National Institutes of Health (NIH) in
developing the NIH-Wide Strategic Plan for Diversity, Equity,
Inclusion, and Accessibility (DEIA). NIH invites input from
stakeholders throughout the scientific research, advocacy, and clinical
practice communities, as well as the general public, regarding the
proposed framework for the NIH-Wide Strategic Plan for DEIA.
Organizations are strongly encouraged to submit a single response that
reflects the views of their organization and their membership as a
whole.
DATES: This RFI is open for public comment for a period of 60 days.
Comments must be received by 11:59:59 p.m. (ET) on April 3, 2022, to
ensure consideration.
ADDRESSES: All comments must be submitted electronically on the
submission website available at https://rfi.grants.nih.gov/?s=61e9a09a971100006d005012.
[[Page 8024]]
FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to: Marina
Volkov, [email protected], 301-496-4147.
SUPPLEMENTARY INFORMATION: The purpose of the NIH-Wide Strategic Plan
for DEIA is to articulate NIH's vision for embracing, integrating, and
strengthening DEIA across all NIH activities to achieve the NIH
mission. The Strategic Plan will capture activities that NIH will
undertake to meet the vision of the Strategic Plan, and will be
organized around accomplishments, needs, opportunities, and challenges
in addressing DEIA in the NIH internal and extramural workforce, its
structure and culture, and the research it supports.
NIH has implemented a range of other initiatives to advance DEIA.
Among them, the UNITE initiative (https://www.nih.gov/ending-structural-racism/unite) was established in 2021 to identify and
address structural racism within the NIH-supported and the greater
scientific community. Please note that an RFI on the Draft 2022-2026
Chief Officer for Scientific Workforce Diversity (COSWD) Strategic Plan
(https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-054.html)
was released on January 12, 2022 and, therefore, is open for public
comment at the same time as this Framework for the NIH-Wide Strategic
Plan for DEIA. You are encouraged to respond to both.
The NIH-Wide Strategic Plan for DEIA is being developed in part as
a response to Report 116-450 on H.R. 7614: Diversity at NIH Working
Group and Strategic Plan, and is responsive to Executive Order 14035
and the Government-Wide Strategic Plan to Advance Diversity, Equity,
Inclusion, and Accessibility in the Federal Workforce (https://www.whitehouse.gov/briefing-room/presidential-actions/2021/06/25/executive-order-on-diversity-equity-inclusion-and-accessibility-in-the-federal-workforce/).
The NIH-Wide Strategic Plan for DEIA will highlight NIH's ongoing
and future efforts to foster DEIA within the biomedical and health
research enterprise. The Framework for the NIH-Wide Strategic Plan for
DEIA, below, articulates NIH's priorities in three key areas
(Objectives): Organizational practices to center and prioritize DEIA
within the workforce; broad efforts to manage and sustain DEIA through
structural and cultural change; and research to promote both workforce
and health equity. These Objectives apply across NIH.
NIH-Wide Strategic Plan for DEIA Framework
Objective 1: Implement Organizational Practices To Center and
Prioritize DEIA in the Workforce
NIH Workforce
Workforce at Institutions Supported by NIH Funding
Objective 2: Grow and Sustain DEIA Through Structural and Cultural
Change
Stewardship
Partnerships and Engagements
Accountability and Confidence
Management and Operations
Objective 3: Advance DEIA Through Research
Workforce Research
Health Research
The NIH seeks comments on any or all of NIH's priorities across the
three key areas (Objectives) articulated in the framework, including
potential benefits, drawbacks or challenges, and other priority areas
for consideration.
NIH encourages organizations (e.g., patient advocacy groups,
professional organizations) to submit a single response reflective of
the views of the organization or membership as a whole.
Responses to this RFI are voluntary and may be submitted
anonymously. Please do not include any personally identifiable
information or any information that you do not wish to make public.
Proprietary, classified, confidential, or sensitive information should
not be included in your response. The Government will use the
information submitted in response to this RFI at its discretion. The
Government reserves the right to use any submitted information on
public websites, in reports, in summaries of the state of the science,
in any possible resultant solicitation(s), grant(s), or cooperative
agreement(s), or in the development of future funding opportunity
announcements. This RFI is for informational and for planning purposes
only and is not a solicitation for applications or an obligation on the
part of the Government to provide support for any ideas identified in
response to it. Please note that the Government will not pay for the
preparation of any information submitted or for use of that
information.
We look forward to your input and hope that you will share this RFI
opportunity with your colleagues.
Dated: February 7, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2022-02972 Filed 2-10-22; 8:45 am]
BILLING CODE 4140-01-P
